One Biosciences Raises €15M Series A to Boost AI-Driven Cell Profiling
One Biosciences (“One Biosciences” or the “Company”), a precision oncology techbio company pioneering clinical grade single-cell tumor transcriptomic profiling, today announced a €15 million Series...